Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-12-047370
Filing Date
2012-08-21
Accepted
2012-08-21 14:52:00
Documents
7
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A v320379_10qa.htm 10-Q/A 21742
  Complete submission text file 0001144204-12-047370.txt   2309032

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT enzn-20120630.xml EX-101.INS 283194
3 XBRL TAXONOMY EXTENSION SCHEMA enzn-20120630.xsd EX-101.SCH 24200
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20120630_cal.xml EX-101.CAL 28381
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20120630_def.xml EX-101.DEF 119784
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20120630_lab.xml EX-101.LAB 218197
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20120630_pre.xml EX-101.PRE 160769
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-12957 | Film No.: 121047540
SIC: 2836 Biological Products, (No Diagnostic Substances)